We use cookies. Find out more about it here. By continuing to browse this site you are agreeing to our use of cookies.
#alert
Back to search results
New

BFT - Research Technician for Dermatology

Massachusetts General Hospital
United States, Massachusetts, Somerville
399 Revolution Drive (Show on map)
Apr 16, 2026
Location: 149 13th St, Charlestown, MA 02129
Start Date: July 1st 2026, 40 hours a week

BFT position in Dermatology available at Massachusetts General Hospital/Harvard Medical School

Dermatology, Cutaneous Biology Research Center

PI: Alexander G. Marneros, MD/PhD

Project: "Novel Mechanisms in Skin Inflammation".

Research Overview

My laboratory investigates how disrupted epithelial differentiation, inflammation, and wound-repair responses drive genetic skin disease and age-related disorders. We combine human genetics, mouse models, multi-omics, and functional studies to uncover disease mechanisms and translate those discoveries into new therapeutic strategies. Our work is highly interdisciplinary, disease-focused, and supported by four major NIH-funded research programs. Although rooted in dermatology and wound healing, our discoveries have also advanced understanding in kidney disease, fibrosis, macrophage biology, angiogenesis, and neovascular age-related macular degeneration.

Research Program I

Keratinocyte-immune cell interactions in cutaneous inflammation

Skin inflammation is shaped not only by immune cells, but also by intrinsic abnormalities in keratinocytes. We study the earliest pathogenic events that initiate inflammatory skin disease, with the goal of identifying interventions that can block inflammation before it becomes chronic. Our work showed that impaired keratinocyte differentiation can be an initiating event in cutaneous inflammation. In particular, we identified AP-2 as a key regulator of the transition from keratinocyte proliferation to terminal differentiation. Loss of this pathway drives keratinocyte hyperproliferation, defective differentiation, and inflammatory changes that resemble psoriasis. We further discovered that AP-2 activity is controlled by KCTD1/KCTD15 complexes, linking epithelial differentiation to inflammatory disease and skin appendage development. These findings highlight keratinocytes as active drivers of inflammation and suggest new therapeutic strategies aimed at restoring epithelial homeostasis.

Research Program II

From wound healing to epithelial differentiation, developmental signaling, and fibrosis

A central theme of our research is that clinical observation can lead to fundamental biological discovery. Our studies of aplasia cutis congenita (ACC), a congenital scalp defect, uncovered the first genetic causes of this disorder and transformed understanding of how epithelial tissues develop and are maintained. We identified pathogenic mutations inBMS1andKCTD1, then used these discoveries to define molecular pathways that regulate epithelial differentiation in both skin and kidney. Our work revealed a critical AP-2/KCTD1 axis required for distal convoluted tubule differentiation and maintenance, and showed that loss of this pathway causes inflammation, fibrosis, and renal dysfunction. We also discovered that ACC is not caused by a primary keratinocyte defect, but instead arises from abnormal cranial neural crest-derived mesenchyme that fails to support formation of the overlying epidermis. This revealed a new mesenchymal-to-epithelial inductive signaling mechanism in scalp development. Together, these studies show how rare disease genetics can uncover broadly important principles of development, tissue homeostasis, and fibrosis.

To apply, please send (1) cover letter highlighting past research experience, your research interests and career goals, (2) CV and (3) the contact info of references via email to Alexander Marneros, MD/PhD, Associate Professor, Harvard Medical School, Massachusetts General Hospital at amarneros@mgh.harvard.edu

https://www.massgeneral.org/dermatology/research/cutaneous-biology-research-center/faculty-labs/alexander-marneros-lab

Education: Bachelors Degree

Experience: Some lab experience preferred, helpful if had experience with mice



The General Hospital Corporation is an Equal Opportunity Employer. By embracing diverse skills, perspectives and ideas, we choose to lead. All qualified applicants will receive consideration for employment without regard to race, color, religious creed, national origin, sex, age, gender identity, disability, sexual orientation, military service, genetic information, and/or other status protected under law. We will ensure that all individuals with a disability are provided a reasonable accommodation to participate in the job application or interview process, to perform essential job functions, and to receive other benefits and privileges of employment.
Applied = 0

(web-bd9584865-9k7lb)